agent strain version f p 102 947c0099h moscow antibiotiki khimioterapiya russian vol 37 11 nov 92 pp 26 28 f f p 103 947c0099h f f p 104 moscow antibiotiki khimioterapiya f f p 105 russian f cso f p 106 articl e samokhodkina v ryzhko f shcherbanyuk v kasatkina r tsurayeva zhigalova antiplagu scientif research institut rostov na donu abstract scarciti data efficaci antibiot agent form incap produc capsular antigen fraction agent version fra sup phenotyp isol exot foci induc diseas human necessit studi prevent action tetracyclin primarili doxycyclin plagu infect induc fractionless agent version end yersinia pesti 231 708 strain fractionless version 231 fra sup 1 fra sup 2 use wherebi 18 20 g albino mice subcutan infect suspens agar cultur plagu microb strain sensit tetracylin determin vitro efficaci doxycyclin tetracyclin prevent experiment albino mice plagu induc 100 g kg inject dose pesti 231 231 fra sup compar analysi ed sub 50 valu doxycyclin experiment plagu albino mice infect pesti 231 231 fra sup 1 000 ld sub 50 inject prevent efficaci inject doxycyclin experiment albino mice plagu induc pesti 231 231 fra sup 1 000 ld sub 50 summar studi show neither increas daili dose increas treatment durat ensur high prevent treatment effici fractionless plagu agent version probabl due chang infecti process develop conclus drawn doxycyclin prolong semi synthet tetracyclin prepar lower therapeut effici experiment plagu albino mice induc strain depriv abil produc fraction manifest higher ed sub 50 valu lower ld sub 50 valu prepar backdrop treatment lower percentag anim surviv intens antibiot therapi import take account possibl decreas tetracyclin effici infect induc fractionless agent version develop treatment prevent procedur stress tabl 3 refer 10 6 russian 4 western